Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis

Fig. 2

Function prediction of two subtypes. Notes: A The differences in clinicopathologic features between two subtypes of gastric cancer examined by the Chi-squared test were presented in pie charts. B GSEA analysis was performed to predict the pathways and functions associated with LM1 and LM2. C The top 20 GO and KEGG signaling pathways in the two subtypes were shown. D The top 20 Hallmark signaling pathways in two subtypes were shown

Back to article page